TractionVarda has successfully launched and returned three missions since 2023 and anticipates completing four missions in 2025. The company also generates revenue through hypersonic flight testing for the U.S. Department of Defense.Organizations InvolvedU.S. Department of DefenseFoundersDelian AsparouhovMarketPharmaceutical manufacturingLocationEl Segundo, California, USACoinvestorsNatural Capital, Shrug Capital, Peter Thiel, Lux Capital, Khosla Ventures, Caffeinated Capital Company Description
Varda Space is focused on transforming space into a platform for the production of critical pharmaceutical components, utilizing microgravity to enhance drug manufacturing processes. The company aims to generate intellectual property through its innovative in-space manufacturing techniques.